Fidelity's increased passive stake to 7.7% is a routine update and does not signal activist intent. Monitor for any future conversion to a 13D filing, which would indicate a shift to active engagement. The filing aligns with Veracyte's recent earnings and buyback announcement, suggesting continued institutional support.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 5 $24.00entry
- T+1 · 11d ago +0.67%α +0.35% · $24.16
- T+5 · 5d ago +2.63%α −0.67% · $24.63
- T+7 · todayOpen
- T+20 · in 17d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
FMR LLC (Fidelity) filed an amended Schedule 13G reporting a 7.7% passive stake in Veracyte as of September 30, 2026, up from the prior filing's 5%+ disclosure. The increase reflects routine portfolio rebalancing by a large passive asset manager and follows Veracyte's Q3 earnings report showing 15% revenue growth and a new $100M buyback authorization.
Key Financial Metrics
Key Facts
- FMR LLC reported beneficial ownership of 6,172,996.40 shares of Veracyte common stock, representing 7.7% of shares outstanding as of September 30, 2026.
- This is an amendment to a Schedule 13G, confirming passive investment intent under Rule 13d-1(b).
- The prior FMR LLC filing (June 5, 2026) reported ownership of 5% or greater but did not specify the exact percentage; the new filing shows an increase to 7.7%.
- Fidelity Management & Research Company LLC is the entity that beneficially owns 5% or greater of the outstanding shares.
- The filing was made one day after Veracyte reported Q3 2026 revenue of $151.8M (+15% YoY) and announced a $100M share repurchase program.
Financial Impact
FMR LLC increased its stake to 7.7% of Veracyte's outstanding shares; at a $4.0B market cap, the stake is valued at approximately $308M.
Risk Factors
- No material risks identified from this passive stake filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0000315066-26-002866 |
| Document: 0000315066-26-002866-index-headers.html | 0000315066-26-002866 |
| Document: 0000315066-26-002866-index.html | 0000315066-26-002866 |
| Document: 0000315066-26-002866.txt | 0000315066-26-002866 |
Track record
22 reports on VCYT
4 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +20.37% at T+20 after the Jun 11, 2026 report. 6 of 6 went positive at some point.
Filters
- Nov 12, 20264d ago SC 13G/A Neutral 3/10 Entry $24.63 Now $24.01 −2.52% settles Dec 11
- Nov 5, 202611d ago SC 13G/A Neutral 3/10 Viewing Entry $24.00 Now $24.01 +0.04% settles Dec 4
- Nov 4, 202612d ago 8-K Neutral 5/10 Entry $24.00 Now $24.01 +0.04% settles Dec 4
- Oct 30, 202617d ago Institutional Cluster Neutral 3/10 Entry $50.01 Now $24.01 −51.99% settles Nov 30
- Oct 28, 202619d ago Insider Cluster Neutral 2/10 Entry $52.17 Now $24.01 −53.98% settles Nov 27
- Oct 28, 202619d ago Insider Cluster Neutral 3/10 Entry $52.17 Now $24.01 −53.98% settles Nov 27
- Oct 27, 202620d ago 144 Neutral 2/10 Entry $50.31 Now $24.01 −52.28% settles Nov 25
- Oct 27, 202620d ago 144 Neutral 2/10 Entry $50.31 Now $24.01 −52.28% settles Nov 25
- Sep 22, 20267w ago Insider Cluster Neutral 2/10 Entry $43.82 to $46.22 Now $24.01 −45.21% ▲ +5.48% +4.79% vs SPY
- Sep 14, 20269w ago Press Release Bullish 6/10 Entry $40.14 to $43.11 Now $24.01 −40.18% ▲ +7.40% +4.68% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers